February 01, 2016
Gilead Announces Promotion of Katie Watson to Executive Vice President, Human Resources
FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 1, 2016--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the promotion of
Katie Watson to Executive Vice President, Human Resources.
Ms. Watson joined Gilead in February 2003 and since that time has taken
on increasing levels of responsibility and management within the HR
organization. Ms. Watson was appointed Vice President of Employee
Development and Rewards in 2012 and was promoted to Senior Vice
President, Human Resources in 2013. Before joining Gilead, she was a
manager of compensation for Applera Corporation, led the HR consulting
practice for TriNet and worked as an HR business partner for DE Shaw &
Co. Ms. Watson holds a degree in Psychology from the University of
California at San Diego and a master's in Organizational Psychology from
“Katie and her team continue to play an invaluable role during a period
of significant hiring and growth at Gilead,” said John C. Martin, PhD,
Chairman and Chief Executive Officer, Gilead Sciences. “During Katie’s
tenure, Gilead has grown from approximately 1,000 to more than 8,000
dedicated employees. Her understanding of the complexities of Gilead’s
business has allowed her to contribute significantly to building an
organization that today reaches millions of patients around the world.”
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.Gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160201006248/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936